Key facts
- This page summarizes Michael Eric Smith's Form 4 filing for Danimer Scientific, Inc. (DNMRQ).
- 1 reported transaction and 0 derivative rows are listed below.
- Accepted by SEC: 03 Jan 2023, 18:01.
Michael Eric Smith - 29 Dec 2022 Form 4 Insider Report for Danimer Scientific, Inc. (DNMRQ)
- Reporting relationship
- Chief Operating Officer
- Issuer ticker
- DNMRQ
- Reported as of
- 29 Dec 2022
- Net transaction value
- -$48,492
- SEC form
- 4
- Accepted by SEC
- 03 Jan 2023, 18:01:29 UTC
- Prior SEC filing
- 22 Feb 2022
- Next SEC filing
- 02 Jan 2024
- Source filing
- View source filing
- Reporting owner signature
- /s/ Michael Smith
Source evidence
Original filing metadata and source links for verification.
5 source fields
Reporting owner
1 detail
Key filing fact
Michael Eric Smith filed Form 4 for Danimer Scientific, Inc. (DNMRQ) on 03 Jan 2023.
Change
- Previous filing in this sequence was filed on 22 Feb 2022.
- Current net transaction value: -$48,492.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
View source filing
Ownership activity is grounded in SEC Form 4 disclosures.
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
DNMR
transaction
Class A Common Stock ("Common Stock")
Tax liability
- Transaction value
- $48,492
- Shares
- -28,358
- Change %
- -8.1%
- Price
- $1.71
- Shares after
- 320,386
- Date
- 29 Dec 2022
- Ownership
- Direct
- Footnotes
- F1, F2
* marks a reported price that did not pass the local price check.
Additional SEC filing notes
Filing notes and footnotes
Explanation of responses 2 footnotes
Footnote F1
Represents the number of shares withheld by the Issuer to satisfy the tax withholding obligations incurred by Mr. Smith as a result of the partial vesting of the Restricted Stock Award (hereinafter defined).
Footnote F2
As previously disclosed, Mr. Smith was granted 377,259 restricted shares of the Common Stock under a restricted stock award (the "Restricted Stock Award"), pursuant to the Danimer Scientific, Inc. 2020 Long-Term Incentive Plan.